| abstract |
4- (Pyrimidin-2-ylmethyl) -7- (4- (trifluoromethoxy) phenyl) -3,4-dihydrobenzo [f] [1,4] oxazepine-5, a selective delayed sodium current inhibitor A crystalline solid form of (2H) -one (Compound I) was prepared and characterized by the solid state. Also provided are processes for making and using the crystalline forms. The present disclosure relates to 4- (pyrimidin-2-ylmethyl) -7- (4- (trifluoromethoxy) phenyl) -3,4-dihydrobenzo [f] [1,4] oxazepin-5 (2H) -one ( The following crystalline forms of Compound I) are provided, including hydrates and solvates thereof. |